EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC 4.0

Development of an individual fitness score ( IFS ) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders

Kentaro Fukumoto, Fumitoshi Kodaka, Naomi Hasegawa, Hiroyuki Muraoka, Hikaru Hori, Kayo Ichihashi, Yuka Yasuda, Hitoshi Iida iD, Kazutaka Ohi iD, Shinichiro Ochi, Kenta Ide, Naoki Hashimoto und 27 weitere

Neuropsychopharmacology Reports · 2023-03 · 43 (1) · 33-39

DOI: 10.1002/npr2.12301 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Neuropsychopharmacology Reports, online erschienen am 16.11.2022. Verfasst von Kentaro Fukumoto und 38 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropsychiatry, School of Medicine, Iwate Medical University, Iwate, Japan. Hauptthemen laut MEDLINE: Mood Disorders, Depression. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Treatment guidelines are designed to assist patients and health care providers and are used as tools for making treatment decisions in clinical situations. The treatment guidelines of the Japanese Society of Mood Disorders establish treatment recommendations for each severity of depression. The individual fitness score (IFS) was developed as a simple and objective indicator to assess whether individual patients are practicing treatment by the recommendations of the depression treatment guidelines of the Japanese Society of Mood Disorders.

Methods

The EGUIDE project members determined the IFS through the modified Delphi method. In this article, the IFS was calculated based on the treatment of depressed patients treated and discharged between 2016 and 2020 at facilities participating in the EGUIDE project. In addition, we compared scores at admission and discharge.

Results

The study included 428 depressed patients (mild n = 22, moderate/severe n = 331, psychotic n = 75) at 57 facilities. The mean IFS scores by severity were statistically significantly higher at discharge than at admission with moderate/severe depression (mild 36.1 ± 34.2 vs. 41.6 ± 36.9, p = 0.49; moderate/severe 50.2 ± 33.6 vs. 55.7 ± 32.6, p = 2.1 × 10–3; psychotic 47.4 ± 32.9 versus 52.9 ± 36.0, p = 0.23).

Conclusion

We developed the IFS based on the depression treatment guideline, which enables us to objectively determine how close the treatment is to the guideline at the time of evaluation in individual cases. Therefore, the IFS may influence guideline‐oriented treatment behavior and lead to the equalization of depression treatment in Japan, including pharmacotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mood DisordersDepressionHumansEast Asian PeoplePatient DischargeJapan

Stichwörter der Autor:innen

Delphi methodEGUIDEdepressionguidelineindividual fitness scoreseverity

Autor:innen und Institutionen

  • Department of Neuropsychiatry, School of Medicine, Iwate Medical University, Iwate, Japan.
  • Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
  • Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan.
  • Department of Psychiatry, Kitasato University School of Medicine, Sagamihara, Japan.
  • Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
  • Department of Neuropsychiatry, University of Tokyo Hospital, Tokyo, Japan.

ORCID-Profile: Hitoshi Iida, Kazutaka Ohi, Masahiro Takeshima, Junya Matsumoto, Kenichiro Miura, Norio Yasui-Furukori, Ken Inada, Ryota Hashimoto

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Fukumoto, K., Kodaka, F., Hasegawa, N., Muraoka, H., Hori, H., Ichihashi, K., Yasuda, Y., Iida, H., Ohi, K., Ochi, S., Ide, K., Hashimoto, N., Usami, M., Nakamura, T., Komatsu, H., Okada, T., Nagasawa, T., Furihata, R., Atake, K., …, & Hashimoto, R. (2023). Development of an individual fitness score ( IFS ) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders. Neuropsychopharmacology Reports, 43(1), 33-39. https://doi.org/10.1002/npr2.12301

Vancouver

Fukumoto K, Kodaka F, Hasegawa N, Muraoka H, Hori H, Ichihashi K, et al. Development of an individual fitness score ( IFS ) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders. Neuropsychopharmacology Reports. 2023;43(1):33-39. doi:10.1002/npr2.12301

BibTeX
@article{Fukumoto2023,
  author = {Fukumoto, Kentaro and Kodaka, Fumitoshi and Hasegawa, Naomi and Muraoka, Hiroyuki and Hori, Hikaru and Ichihashi, Kayo and Yasuda, Yuka and Iida, Hitoshi and Ohi, Kazutaka and Ochi, Shinichiro and Ide, Kenta and Hashimoto, Naoki and Usami, Masahide and Nakamura, Toshinori and Komatsu, Hiroshi and Okada, Tsuyoshi and Nagasawa, Tatsuya and Furihata, Ryuji and Atake, Kiyokazu and Kido, Mikio and Kikuchi, Saya and Yamagata, Hirotaka and Kishimoto, Taishiro and Makinodan, Manabu and Horai, Tadasu and Takeshima, Masahiro and Kubota, Chika and Asami, Takeshi and Katsumoto, Eiichi and Hishimoto, Akitoyo and Onitsuka, Toshiaki and Matsumoto, Junya and Miura, Kenichiro and Yamada, Hisashi and Yasui-Furukori, Norio and Watanabe, Koichiro and Inada, Ken and Otsuka, Kotaro and Hashimoto, Ryota},
  title = {Development of an individual fitness score ( IFS ) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders},
  journal = {Neuropsychopharmacology Reports},
  year = {2023},
  volume = {43},
  number = {1},
  pages = {33--39},
  doi = {10.1002/npr2.12301}
}
Kostenlos starten →